Working party members and contributors

Information on authorship and revision

In collaboration with

Last modified:
5 January 2015 23:36:06

Author(s):

• Cancer Council Australia Sarcoma Guidelines Working Party — Author

Cite this page

Cancer Council Australia Sarcoma Guidelines Working Party. [Version URL: https://wiki.cancer.org.au/australiawiki/index.php?oldid=98697, cited 2019 Apr 21]. Available from https://wiki.cancer.org.au/australia/Guidelines:Sarcoma/Working_party_members_and_contributors. In: Cancer Council Australia Sarcoma Guidelines Working Party. Clinical practice guidelines for the management of adult onset sarcoma. Sydney: Cancer Council Australia. Available from: https://wiki.cancer.org.au/australia/Guidelines:Sarcoma.

Working party members and contributors

Working party member	Clinical questions
Associate Professor Gelareh Farshid	Clinical question:What are the measures to assess treatment response in BSSTs? (body of evidence· view literature search summary)— Author Clinical question:What is the role of prognostic factors in management of BSTTs? (body of evidence· view literature search summary)— Co-author
Assoc Prof Chris Hemmings	Clinical question:What is the impact of delay in referral to a specialist centre in BSTTs? (body of evidence· view literature search summary)— Author Clinical question:What is the outcome of a second opinion in BSTT pathology? (body of evidence· view literature search summary)— Author
Professor David Thomas FRACP, PhD	Clinical question:What is the role for systemic therapy in advanced soft-tissue sarcoma? (body of evidence· view literature search summary)— Author
Dr Raghu Gowda MSc MD MRCP(UK) FRCR(UK) FRANZCR	Clinical question:What is the evidence that pre-operative radiotherapy is superior to post-operative radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage and morbidity? (body of evidence· view literature search summary)— Author Clinical question:What is the evidence that radiotherapy, either pre-operative or post-operative, decreases local recurrence or improves survival in retroperitoneal sarcomas? (body of evidence· view literature search summary)— Author Clinical question:What is the evidence that radiotherapy, either pre-operative or post-operative, decreases local recurrence or improves survival in truncal sarcomas? (body of evidence· view literature search summary)— Author
Dr Grant Pang	Clinical question:What are the factors influencing the extent of surgery in BSTTs? (body of evidence· view literature search summary)— Co-author
Dr Jayesh Desai	Clinical question:What is the role for systemic therapy in advanced soft-tissue sarcoma? (body of evidence· view literature search summary)— Author
Dr Julie Chu	Clinical question:What is the evidence for radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage? (body of evidence· view literature search summary)— Author Clinical question:What is the evidence that pre-operative radiotherapy is superior to post-operative radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage and morbidity? (body of evidence· view literature search summary)— Co-author
Dr Kirsten Gormly	Clinical question:What are the most appropriate imaging modalities for diagnosis and staging of BSTTs? (body of evidence· view literature search summary)— Author
Dr Marcus Foo FRANZCR	Clinical question:What is the evidence for radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage? (body of evidence· view literature search summary)— Co-author Clinical question:What is the evidence that pre-operative radiotherapy is superior to post-operative radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage and morbidity? (body of evidence· view literature search summary)— Co-author
Dr Paul Stalley	Clinical question:What are the factors that impact on the choice of reconstructive options in BSTTs? (body of evidence· view literature search summary)— Co-author
Professor Peter Choong FRACS, FAOrth A, MBBS MD	Clinical question:What are the factors influencing the extent of surgery in BSTTs? (body of evidence· view literature search summary)— Author Clinical question:What are the factors that impact on the choice of reconstructive options in BSTTs? (body of evidence· view literature search summary)— Co-author
Professor Martin Tattersall SCD, MD FRACP	Clinical question:What is the role for adjuvant systemic therapy for adults with BSTT? (body of evidence· view literature search summary)— Author
Dr Richard Boyle FRACS FA(Orth)A	Clinical question:What are the factors that impact on the choice of reconstructive options in BSTTs? (body of evidence· view literature search summary)— Co-author
Dr Roger Woods MBBS, FRACS	Clinical question:What are the factors that impact on the choice of reconstructive options in BSTTs? (body of evidence· view literature search summary)— Author Clinical question:What is the role of sentinel lymph node biopsy in patients with BSTT? (body of evidence· view literature search summary)— Author
Associate Professor Sam Ngan, MBBS, FRCSE, FRANZCR	Clinical question:What are the indications for IMRT, brachytherapy, intraoperative radiotherapy (IORT), extra-corporeal radiotherapy and particle therapy in the management of BSTTs? (body of evidence· view literature search summary)— Co-author Clinical question:What is the evidence for radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage? (body of evidence· view literature search summary)— Co-author Clinical question:What is the evidence that pre-operative radiotherapy is superior to post-operative radiotherapy in limb and extremity soft tissue sarcoma in terms of local recurrence, survival and limb salvage and morbidity? (body of evidence· view literature search summary)— Co-author
Dr Sarat Chander FRANZCR	Clinical question:What are the indications for IMRT, brachytherapy, intraoperative radiotherapy (IORT), extra-corporeal radiotherapy and particle therapy in the management of BSTTs? (body of evidence· view literature search summary)— Author
Dr Steve Chryssidis	Clinical question:What are the most appropriate imaging modalities for diagnosis and staging of BSTTs? (body of evidence· view literature search summary)— Co-author Clinical question:What is the ideal duration, frequency and modality of follow-up for BSTTs? (body of evidence· view literature search summary)— Co-author
Associate Professor Susan Neuhaus	Clinical question:What is the ideal duration, frequency and modality of follow-up for BSTTs? (body of evidence· view literature search summary)— Author Clinical question:What is the role of regional chemotherapy in BSTTs? (body of evidence· view literature search summary)— Author Clinical question:What preoperative optimisation strategies improve outcomes in BSTTs? (body of evidence· view literature search summary)— Author
Dr Warren Hargreaves	Clinical question:Does referral to a specialist centre improve outcomes in BSTTs? (body of evidence· view literature search summary)— Author Clinical question:What is the role of prognostic factors in management of BSTTs? (body of evidence· view literature search summary)— Author

Name	Affiliation
Dr Mandy Ballinger	Working Party member, Peter MacCallum Cancer Centre, VIC
Marianne Griffin	Working Party member, Oncology Nurse, VIC
Dr Helen Irving	Working Party member, Paediatric Oncologist, Royal Children's Hospital, QLD
Dr Jonathan Karpelowsky	Working Party member, Paediatric Surgeon, The Children's Hospital at Westmead NSW
Dr Geoffrey McCowage	Working Party member, Paediatric Oncologist, The Children's Hospital at Westmead NSW
Dr Gillian Mitchell	Working Party member, Clinical Oncologist, Peter MacCallum Cancer Centre, VIC
Dr Marianne Phillips MBCHB, FRCP, FRCPCH, FRACP	Working Party member, Consultant Paediatric and Adolescent Oncologist, Princess Margaret Hospital for Children, WA
Leigh Webb (QLD)	Consumer representative to the Working Party